References
- Canney P. A., Hatton M. Q. F. The prevalence of menopausal symptoms in patients treated for breast cancer. Clin. Oncol. 1994; 6: 297–9
- Kelsey J. L., Berkowitz G. S. Breast cancer epidemiology. Cancer Res. 1988; 48: 5615–23
- Marsden J., Sacks N. P. M. Hormone replacement therapy in breast cancer. Endocrine-related Cancer 1996; 3: 81–97
- Stoll B. A. Hormone replacement therapy in women treated for breast cancer. Eur. J. Cancer Clin. Oncol 1989; 25: 1909–13
- Wile A. G., Opfell R. W., Margileth D. A. Hormone replacement therapy in previously treated breast cancer patients. Am. J. Surg. 1993; 165: 372–5
- DiSaia P. J., Odicino F., Grosen E. A., et al. Hormone replacement therapy in breast cancer. Lancet 1993; 342: 1232
- Powles T. P., Casey S., O'Brien M., Hickish T. Hormone replacement after breast cancer. Lancet 1993; 342: 60
- Bluming A. Z., Wile A. G., Schain W., et al. Hormone replacement therapy in women with previously treated primary breast cancer (Abstract). Proceedings of Annual Meeting of American Society of Clinical Oncology 1994; 13: A137
- Eden J. A., Bush T., Nand S., Wren B. G. A case-controlled study of combined continuous oestrogen replacement therapy amongst women with a personal history of breast cancer. Menopause 1995; 2: 67–72